Helen of Troy Limited
Braun (Healthcare)
Helen of Troy is a global consumer products company that owns and operates the Braun healthcare product line under license, founded in 1968 in El Paso, Texas, USA. With projected consolidated revenue of ~$1.9 billion, the company generates 71-72% of sales from the US market. Its Braun ThermoScan ear thermometers are the #1 pediatrician-recommended brand in America.
Strengths: Braun ThermoScan holds dominant market share in pediatric thermometers; asset-light licensing model generates high margins on premium-priced healthcare products; multi-brand portfolio including OXO, Hydro Flask provides revenue diversification; strong omnichannel retail presence across major US retailers.
Weaknesses: Revenue declining 4.6-5.8% due to inflationary pressure on consumer spending; heavy US market dependence (71-72% of sales); own no core manufacturing assets (relies on contract manufacturers); non-healthcare product lines dilute category purity score.Read MoreShow Less
Strengths: Braun ThermoScan holds dominant market share in pediatric thermometers; asset-light licensing model generates high margins on premium-priced healthcare products; multi-brand portfolio including OXO, Hydro Flask provides revenue diversification; strong omnichannel retail presence across major US retailers.
Weaknesses: Revenue declining 4.6-5.8% due to inflationary pressure on consumer spending; heavy US market dependence (71-72% of sales); own no core manufacturing assets (relies on contract manufacturers); non-healthcare product lines dilute category purity score.
Listed market data
HELE · NASDAQ · weeklyHistory →- Market cap
- $670 M
- Share price
- USD 28.99
- 1Y change
- +52.9%
- Recent change
- -3.1%
- Since first close
- ×92.9
- Revenue (TTM)
- $1.8 B
10-22 → 10-23
from 1976-07
Financial history
Full market history- 2026-10USD 28.99$670 M+5.8%
- 2026-09USD 27.41$654 M-8.9%
- 2026-08USD 30.10$718 M+8.9%
- 2026-07USD 27.63$659 M-5.0%
- 2026-06USD 29.07$694 M+7.1%
- 2026-05USD 27.14$648 M+17.2%
- 2026-04USD 23.15$553 M+60.5%
- 2026-03USD 14.42$344 M-18.3%
- 2026-02USD 17.64$421 M+6.5%
- 2026-01USD 16.56$395 M-22.1%
- 2025-12USD 21.25$507 M+12.1%
- 2025-11USD 18.95$452 M—
In the press
All coverage →5 latest headlines- UBS lifts target for Helen of Troy stock to USD 29.00 - ad-hoc-news.dewww.ad-hoc-news.de2026-10-20
- What the Helen of Troy is That?!? National Guard edition - PoPvillewww.popville.com2026-10-20
- Is Helen of Troy (HELE) Stock Undervalued Right Now?finance.yahoo.com2026-10-16
- Is Helen of Troy (HELE) Stock Undervalued Right Now? - Yahoo Financefinance.yahoo.com2026-10-16
- Helen of Troy (HELE) Is Attractively Priced Despite Fast-paced Momentumfinance.yahoo.com2026-10-13
• Braun ThermoScan ear thermometers – #1 pediatrician-recommended brand
• Braun blood pressure monitors for home cardiovascular monitoring
• Braun No Touch and forehead thermometers for family use
• Home environment products including air purifiers and humidifiers
• Vicks-branded healthcare products under license
• Personal care and grooming health devices
| Fiscal year | Revenue | Net income |
|---|---|---|
| 2026 | $1.8 B | −$899 M |
| 2025 | $1.9 B | $124 M |
| 2024 | $2 B | $169 M |
| 2023 | $2.1 B | $143 M |
| 2022 | $2.2 B | $224 M |
Annual results from company filings (SEC XBRL), converted to US dollars.
Quick Facts
Headquarters
El Paso, Texas, United States
Founded
1968
Employees
15000+
Revenue
~$1.9 B
Market cap
$670 M
Factories
Contract manufacturing in 8+ countries
Presence
90+ Countries
Listing
NASDAQ: HELE
Categories
Related
Similar listed companies
- Eli Lilly and Company· $1.1 T
- Allergan Aesthetics· $504 B
- F. Hoffmann-La Roche AG· $372 B
- Procter & Gamble· $370 B
- Merck Animal Health· $360 B
- Abbott Laboratories· $183 B
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website NASDAQ: HELE